Watch Now Agenda *Agenda subject to change 6:30 PM Guest Arrival and Cocktail Reception 7:00 PM Welcome Participants Tyler Watson Executive Vice President of Marketing, The Atlantic Susan Sweeney Executive Vice President of Obesity and Related Conditions, Amgen 7:05 PM The Defining Scale Shift in Obesity Therapeutics Summary The first wave of obesity medications proved that biology works and sparked extraordinary demand
Melanotan II (MT-II) is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH)
KLOW Blend BPC-157 + TB-500 + GHK-Cu + KPV Lyophilized Vial Description The KLOW Blend is the most comprehensive recovery research stack available, combining four synergistic peptides in a single lyophilized vial: BPC-157, TB-500, GHK-Cu, and KPV
When a person stops taking the medication, its effects halt, too, and a person may return to their previous calorie consumption
Applicable Procedure Codes: 37243, 75984, 79445, S2095